Breakthrough In Treatment For Kidney Dialysis Patients
A ground-breaking medical approach which could substantially improve the quality of life for over a million kidney dialysis patients, and bring huge savings to health services around the globe, is one step closer to becoming a reality, thanks to NESTA (the National Endowment of Science, Technology and the Arts) – the organisation that backs UK innovation.
NESTA has invested £95,000 in a university spin-out, Veryan Medical Limited, based at London’s Imperial College, to further develop their ground-breaking approach. The company has been financed to date by NPI Ventures Limited and Imperial College Innovations.
Veryan are dedicated to developing a number of novel medical devices to address urgent, unmet medical needs in the field of vascular disease, the greatest cause of death in the modern world. Their inventions are designed to recreate the natural swirling fluid flow of the body and prevent the development of disease. The first device to be tested in clinical human trials will be the SwirlGraft™ vascular access graft.
Currently, there are over one million people requiring regular connection to a kidney dialysis machine in order to sustain their lives. A majority of these patients have a synthetic vessel, called a vascular access graft, inserted beneath the skin to facilitate regular hypodermic puncturing and to maximize blood-flow to the dialysis machine. However, these grafts typically develop a potentially lethal disease, called ‘intimal hyperplasia’, which can block the downstream junction with the natural vessel in just a few months. This results in most grafts requiring replacement within a year, and many patients require remedial surgery up to three times a year.
SwirlGraft™ has the potential to be the most effective solution to this problem. By ensuring appropriate swirling blood flow through the dialysis graft and into the downstream vein, it stands to greatly reduce the disease by eliminating the stagnant flow regions where intimal hyperplasia proliferates.
The SwirlGraft™ device has been developed by Professor Colin Caro at Imperial College, and comes on the back of research dating back to 1966. Professor Caro is considered to be a world expert on the links between the physics of blood flow and disease. Veryan Medical is headed up by Philip Birch who brings substantial expertise of building and funding early stage healthcare companies.
NESTA’s investment will be used to develop the SwirlGraft™ device from the current experimental proof of concept through to clinical proof of concept. The trials will be based in the Netherlands and will involve 25 dialysis patients fitted with SwirlGraft™ for their vascular access, monitored for a year.
Mark White, NESTA’s Invention and Innovation Director, said: “We are delighted to be investing in a product which meets an urgent need for improved clinical performance, as well as bringing huge benefits to dialysis patients from around the world.”
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...